Core Viewpoint - CareCloud, Inc. has announced a formal plan to address 14 months of accumulated unpaid dividends on its Series B Preferred Stock, reflecting the company's financial turnaround and confidence in its growing recurring revenues and margins [1][4]. Dividend Plan - The company plans to issue double monthly dividend payments, starting with the January 2026 dividend, which will include one regular payment and one additional payment for the arrears [2][6]. - The total amount of accumulated dividends in arrears is approximately $3.9 million, equating to $2.55 per share of Series B Preferred Stock [6]. Financial Strength and Commitment - CareCloud's leadership emphasizes the company's renewed financial strength, operational efficiency, and commitment to fulfilling obligations to shareholders [4][6]. - The double-payment structure is designed to maintain regular monthly dividends while systematically addressing the arrears without compromising the company's growth trajectory [4][6]. Dividend Payment Details - Dividends on the Series B Preferred Stock are cumulative and payable monthly, with payments expected around the 15th of each month [4][6]. - The company anticipates completing the catch-up payments by the end of the first quarter of 2027 [6].

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark one) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36529 CareCloud, Inc. (Exact name of registrant as specified in its charter) Delaware 22-3832302 (State or other jurisdicti ...

Exhibit 99.1 CareCloud Reports Third Quarter 2025 Results Raises Revenue Guidance, Completes Medsphere Acquisition and Accelerates AI Initiative SOMERSET, N.J. November 06, 2025 (GLOBE NEWSWIRE) - CareCloud, Inc. (Nasdaq: CCLD, CCLDO), a leader in healthcare technology and generative AI solutions, today announced strong financial results for the quarter ended September 30, 2025, and is increasing its full-year 2025 revenue guidance to $117 – $119 million, up from the initial range of $111 – $114 million. Ca ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

Financial Performance - For the six months ended June 30, 2025, net revenue was $55.009 million, a slight increase from $54.052 million in the same period of 2024[157]. - Adjusted EBITDA for the three months ended June 30, 2025, was $6.529 million, compared to $6.389 million in 2024, reflecting a year-over-year increase of approximately 2.2%[157]. - GAAP net income for the six months ended June 30, 2025, was $4.850 million, significantly higher than $1.433 million in 2024, indicating a growth of over 238%[157]. - GAAP operating income for the three months ended June 30, 2025, was $2.996 million, compared to $2.271 million in 2024, representing an increase of approximately 32%[157]. - GAAP net income for Q2 2025 was $2.9 million, compared to $1.7 million in Q2 2024, representing a year-over-year increase of 73.5%[160]. - Non-GAAP adjusted net income for Q2 2025 was $3.3 million, up from $3.0 million in Q2 2024, reflecting a 10.9% increase[160]. - Net income was $2.9 million for the three months ended June 30, 2025, compared to $1.7 million for the same period in 2024[192]. Revenue and Expenses - Total net revenue for Q2 2025 was $27.4 million, a decrease of $713,000 or 3% from $28.1 million in Q2 2024[176]. - Revenue from technology-enabled business solutions accounted for approximately 69% of total revenue in Q2 2025, compared to 68% in Q2 2024[163]. - Direct operating costs for Q2 2025 were $14.5 million, down 5% from $15.2 million in Q2 2024[178]. - Selling and marketing expenses decreased by 33% to $1.1 million in Q2 2025 from $1.7 million in Q2 2024[178]. - General and administrative expenses increased by 8% to $4.4 million in Q2 2025 compared to $4.0 million in Q2 2024[178]. - Restructuring costs significantly decreased by 80% to $23,000 in Q2 2025 from $116,000 in Q2 2024[178]. Cash Flow and Capital Expenditures - Cash provided by operations was $12.5 million for the six months ended June 30, 2025, compared to $8.3 million for the same period in 2024, representing a 50% increase[197]. - Total cash as of June 30, 2025, was $10.4 million, with net working capital of $14.9 million[191]. - The company had no borrowings under the credit facility as of June 30, 2025, compared to $5.0 million outstanding as of June 30, 2024[191]. - Capital expenditures were $1.8 million for the six months ended June 30, 2025, compared to $425,000 for the same period in 2024[198]. Operational Insights - Offshore operations in Pakistan and Sri Lanka accounted for approximately 18% and 14% of total expenses for the six months ended June 30, 2025, and 2024, respectively[152]. - The company has approximately 300 experienced health industry experts in the U.S. and a specialized offshore workforce of about 3,600 team members, which is approximately 18% of the cost of comparably educated and skilled workers in the U.S.[150]. - The company’s technology-enabled business solutions include a full suite of proprietary cloud-based solutions for healthcare providers, enhancing operational efficiency and patient care[148]. - The company served approximately 40,000 providers as of June 30, 2025, consistent with the previous year[162]. Expense Breakdown - Selling and marketing expenses decreased by $546,000 or 33% to $1.1 million for the three months ended June 30, 2025, compared to $1.7 million for the same period in 2024[179]. - General and administrative expenses increased by $330,000 or 8% to $4.4 million for the three months ended June 30, 2025, compared to $4.0 million for the same period in 2024[180]. - Research and development expenses decreased by approximately $35,000 or 3% to $1.0 million for the three months ended June 30, 2025, compared to $1.1 million for the same period in 2024[181]. - Depreciation expense increased by $91,000 to $594,000 for the three months ended June 30, 2025, compared to $503,000 for the same period in 2024[182]. - Amortization expense decreased by $423,000 or 13% to $2.8 million for the three months ended June 30, 2025, compared to $3.2 million for the same period in 2024[183]. Company Classification - The company is classified as a smaller reporting company and is not required to provide information under Item 305(e) of Regulation S-K[202].

[Executive Summary](index=1&type=section&id=Executive%20Summary) [Financial & Operational Highlights](index=1&type=section&id=Financial%20%26%20Operational%20Highlights) CareCloud achieved its first positive GAAP EPS of $0.04 in Q2 2025, with year-to-date revenue, adjusted EBITDA, and free cash flow all increasing, alongside strategic AI and acquisition initiatives Second Quarter 2025 Financial Highlights (vs. Q2 2024) | Metric | Q2 2025 | Q2 2024 | Change | | :--- | :--- | :--- | :--- | | Revenue | $27.4 million | $28.1 million | -2.5% | | GAAP Net Income | $2.9 million | $1.7 million | +73% | | GAAP EPS | $0.04 | ($0.14) | N/A | | Adjusted Net Income | $3.3 million | $3.0 million | +10% | | Adjusted EBITDA | $6.5 million | $6.4 million | +1.6% | Year-to-Date 2025 Financial Highlights (vs. YTD 2024) | Metric | YTD 2025 | YTD 2024 | Change | | :--- | :--- | :--- | :--- | | Revenue | $55.0 million | $54.1 million | +1.7% | | GAAP Net Income | $4.9 million | $1.4 million | +238% | | GAAP EPS | $0.02 | ($0.24) | N/A | | Adjusted EBITDA | $12.1 million | $10.1 million | +20% | | Free Cash Flow | $9.0 million | $4.9 million | +85% | - Recent strategic updates include achieving the first quarter of **positive GAAP EPS** since going public, launching an AI Center of Excellence set to scale to **500 team members**, and completing **two acquisitions** with more under evaluation[4](index=4&type=chunk) [Management Commentary](index=2&type=section&id=Management%20Commentary) Management highlighted the AI Center of Excellence as pivotal for innovation and efficiency, emphasizing positive GAAP EPS as a historic milestone achieved through successful turnaround efforts and strategic reinvestment - The launch of the AI Center of Excellence is a pivotal moment, intended to automate clinical workflows, optimize revenue cycle management, and position CareCloud at the forefront of intelligent healthcare transformation[5](index=5&type=chunk) - The company achieved **positive GAAP EPS** for the first time since going public in 2014, signaling continued momentum and financial strength following a successful turnaround in 2024[5](index=5&type=chunk) - CareCloud reported its **fifth consecutive quarter of positive GAAP net income** and is using internally generated free cash flow to pay monthly preferred stock dividends while reinvesting additional profits for future growth[5](index=5&type=chunk) [2025 Full-Year Guidance](index=2&type=section&id=2025%20Guidance%3A%20Poised%20for%20Growth) CareCloud reconfirmed its 2025 full-year guidance, projecting revenues of $111-$114 million, Adjusted EBITDA of $26-$28 million, and positive GAAP EPS of $0.10-$0.13 Fiscal Year 2025 Forward-Looking Guidance | Metric | Guidance Range | | :--- | :--- | | Revenue | $111 – $114 million | | Adjusted EBITDA | $26 – $28 million | | GAAP Net Income Per Share (EPS) | $0.10 – $0.13 | - The revenue guidance is based on expectations from existing clients, organic growth from new clients, and anticipated small tuck-in acquisitions[7](index=7&type=chunk) [Financial Statements](index=5&type=section&id=Financial%20Statements) [Condensed Consolidated Balance Sheets](index=5&type=section&id=CONDENSED%20CONSOLIDATED%20BALANCE%20SHEETS) As of June 30, 2025, CareCloud's total assets increased to **$75.2 million**, liabilities decreased to **$19.2 million**, and shareholders' equity grew to **$56.1 million** Balance Sheet Summary ($ in thousands) | Account | June 30, 2025 | December 31, 2024 | | :--- | :--- | :--- | | **Total Assets** | **$75,244** | **$71,614** | | Total current assets | $31,090 | $24,800 | | **Total Liabilities** | **$19,168** | **$21,840** | | Total current liabilities | $16,240 | $19,580 | | **Total Shareholders' Equity** | **$56,076** | **$49,774** | [Condensed Consolidated Statements of Operations](index=6&type=section&id=CONDENSED%20CONSOLIDATED%20STATEMENTS%20OF%20OPERATIONS) Q2 2025 revenue was **$27.4 million**, with operating income rising to **$3.0 million** and net income growing **73%** to **$2.9 million**, while year-to-date net income surged to **$4.9 million** Statement of Operations Summary - Three Months Ended June 30 ($ in thousands) | Metric | 2025 | 2024 | | :--- | :--- | :--- | | Net Revenue | $27,377 | $28,090 | | Operating Income | $2,996 | $2,271 | | Net Income | $2,902 | $1,674 | | Net Income (Loss) Attributable to Common Shareholders | $1,537 | $(2,249) | | EPS (basic and diluted) | $0.04 | $(0.14) | Statement of Operations Summary - Six Months Ended June 30 ($ in thousands) | Metric | 2025 | 2024 | | :--- | :--- | :--- | | Net Revenue | $55,009 | $54,052 | | Operating Income | $5,015 | $2,400 | | Net Income | $4,850 | $1,433 | | Net Income (Loss) Attributable to Common Shareholders | $674 | $(3,802) | | EPS (basic and diluted) | $0.02 | $(0.24) | [Condensed Consolidated Statements of Cash Flows](index=7&type=section&id=CONDENSED%20CONSOLIDATED%20STATEMENTS%20OF%20CASH%20FLOWS) For the six months ended June 30, 2025, net cash from operations increased to **$12.5 million**, leading to a **$5.3 million** net increase in cash and a period-end balance of **$10.4 million** Cash Flow Summary - Six Months Ended June 30 ($ in thousands) | Activity | 2025 | 2024 | | :--- | :--- | :--- | | Net cash provided by operating activities | $12,521 | $8,345 | | Net cash used in investing activities | $(3,503) | $(3,471) | | Net cash used in financing activities | $(3,694) | $(5,512) | | **Net increase (decrease) in cash** | **$5,295** | **$(714)** | | **Cash - End of the period** | **$10,440** | **$2,617** | [Non-GAAP Financial Measures](index=8&type=section&id=Non-GAAP%20Financial%20Measures) [Reconciliation of Non-GAAP Measures](index=8&type=section&id=RECONCILIATION%20OF%20NON-GAAP%20FINANCIAL%20MEASURES) CareCloud provides reconciliations for non-GAAP measures, showing Q2 2025 Adjusted EBITDA at **$6.5 million**, non-GAAP adjusted net income at **$3.3 million**, and year-to-date free cash flow at **$9.0 million** Adjusted EBITDA Reconciliation ($ in thousands) | Period | GAAP Net Income | Adjusted EBITDA | | :--- | :--- | :--- | | Q2 2025 | $2,902 | $6,529 | | Q2 2024 | $1,674 | $6,389 | | YTD 2025 | $4,850 | $12,124 | | YTD 2024 | $1,433 | $10,076 | Non-GAAP Adjusted Net Income Reconciliation ($ in thousands) | Period | GAAP Net Income | Non-GAAP Adjusted Net Income | | :--- | :--- | :--- | | Q2 2025 | $2,902 | $3,281 | | Q2 2024 | $1,674 | $2,958 | | YTD 2025 | $4,850 | $5,571 | | YTD 2024 | $1,433 | $3,178 | Free Cash Flow Reconciliation ($ in thousands) | Period | Net cash provided by operating activities | Free Cash Flow | | :--- | :--- | :--- | | YTD 2025 | $12,521 | $9,018 | | YTD 2024 | $8,345 | $4,874 | [Explanation of Non-GAAP Measures](index=10&type=section&id=Explanation%20of%20Non-GAAP%20Financial%20Measures) Management utilizes non-GAAP measures like Adjusted EBITDA and Adjusted Net Income to clarify operational trends by excluding non-cash or non-recurring items such as stock-based compensation and transaction costs - Management uses non-GAAP financial measures to supplement GAAP results, believing they help investors understand short-term and long-term financial and operational trends by excluding certain non-cash or non-recurring items[36](index=36&type=chunk) - Adjusted EBITDA is used to evaluate operating performance and liquidity by excluding non-cash expenses (like depreciation, amortization, stock-based compensation) and expenses related to investing or financing transactions[37](index=37&type=chunk) - Specific items excluded from various non-GAAP measures include: foreign exchange loss, stock-based compensation, amortization of purchased intangible assets, transaction costs, integration costs, and restructuring costs[41](index=41&type=chunk)[42](index=42&type=chunk)[44](index=44&type=chunk) [Other Information](index=2&type=section&id=Other%20Information) [Capital Structure](index=2&type=section&id=Capital) As of June 30, 2025, CareCloud had **42,322,039** common shares outstanding, alongside Series A and B Preferred Stock totaling **2,495,902** shares, accruing dividends at **8.75%** annually - As of June 30, 2025, the Company had **42,322,039 shares of common stock outstanding**[6](index=6&type=chunk) - There were **984,530 shares of Series A Preferred Stock** and **1,511,372 shares of Series B Preferred Stock** outstanding, both accruing dividends at a rate of **8.75% per annum**[6](index=6&type=chunk) [Conference Call and Other Disclosures](index=3&type=section&id=Conference%20Call%20and%20Other%20Disclosures) This section details the investor conference call, explains the use of non-GAAP financial measures per SEC Regulation G, and includes forward-looking statement disclaimers - Management will host a conference call at **8:30 a.m. Eastern Time** to discuss the results, with a live webcast available on the company's investor relations website[9](index=9&type=chunk) - The press release contains forward-looking statements regarding future financial performance, growth, and business outlook, which are subject to various risks and uncertainties[12](index=12&type=chunk)[13](index=13&type=chunk) - The company uses non-GAAP financial measures, as defined by SEC Regulation G, and provides reconciliations to the most directly comparable GAAP measures within the press release[11](index=11&type=chunk)

Core Points - CareCloud, Inc. held its 2025 Annual Shareholders' Meeting on May 27, 2025, where shareholders re-elected Anne Busquet, Bill Korn, and Lawrence Sharnak to the Board for another two-year term [1][2] - Shareholders approved the advisory compensation for the Company's named executive officers as disclosed in the 2025 Proxy Statement [1][7] - Rosenberg Rich Baker Berman, P.A. was appointed as the independent registered public accounting firm for the year ending December 31, 2025 [1][7] Group 1 - Anne Busquet has over 30 years of executive experience with American Express and Interactive Corp [2] - Bill Korn served as Chief Financial Officer for 10 years before retiring in October 2023 [2] - Lawrence Sharnak held various senior leadership roles at American Express for more than 30 years [2] Group 2 - CareCloud provides technology-enabled solutions aimed at improving financial and operational performance, streamlining clinical workflows, and enhancing patient experience [4] - The Company serves over 40,000 providers, helping them improve patient care while reducing administrative burdens and operating costs [4]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark one) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36529 CareCloud, Inc. (Exact name of registrant as specified in its charter) Delaware 22-3832302 (I.R.S. Employer Identificatio ...

Exhibit 99.1 CareCloud Delivers Growth and Strong Cash Flow in Q1 2025, Advances AI and Acquisition Strategy SOMERSET, N.J. May 6, 2025 (GLOBE NEWSWIRE) - CareCloud, Inc. (Nasdaq: CCLD, CCLDO), a leader in healthcare technology and generative AI solutions, today announced strong financial results for the three months ended March 31, 2025. CareCloud's strategic execution, AI-driven innovation, and disciplined financial management have fueled a transformational turnaround, positioning the Company for sustaine ...

Core Viewpoint - CareCloud, Inc. has declared monthly cash dividends for its Series A and Series B Preferred Stocks for March and April 2025, reflecting the company's commitment to returning value to shareholders [1][2]. Dividend Details - The monthly dividend for Series A Preferred Stock is $0.18229 per share for both March and April 2025, with an additional payment of $0.04688 per share [2]. - The monthly dividend for Series B Preferred Stock is also $0.18229 per share for both March and April 2025 [2][3]. - The ex-dividend and record dates for both series are March 31, 2025, and April 30, 2025, respectively, with payment dates set for April 15, 2025, and May 15, 2025 [2][4]. Preferred Stock Information - Series A Preferred Stock has a cumulative cash dividend rate of 8.75% per annum based on a $25.00 liquidation preference, equating to $2.1875 per annum per share [2][3]. - Series B Preferred Stock also has a cumulative cash dividend rate of 8.75% per annum based on a $25.00 liquidation preference, equating to $2.1875 per annum per share [3]. - The Series A Preferred Stock was converted into common stock on March 6, 2025, leading to its voluntary delisting from the Nasdaq Global Market [5]. Redemption Options - The company has the option to redeem Series A Preferred Stock at a price of $25.00 per share, plus any accumulated and unpaid dividends, with a notice period of 30 to 60 days [5]. - For Series B Preferred Stock, the redemption prices vary based on the date, starting at $25.50 per share for redemptions on or after February 15, 2025 [6].